Clinical outcome measures following plasma exchange for MG exacerbation
Abstract Our objective is to report longitudinal results of the MG‐ADL, MG‐Composite, MG‐MMT, and MG‐QoL15 in an open‐label trial of therapeutic plasma exchange in myasthenia gravis. Ten MG patients experiencing exacerbation had assessments prior to, immediately following, and at selected time point...
Main Authors: | Shruti M. Raja, James F. Howard Jr, Vern C. Juel, Janice M. Massey, Manisha Chopra, Jeffrey T. Guptill |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-10-01
|
Series: | Annals of Clinical and Translational Neurology |
Online Access: | https://doi.org/10.1002/acn3.50901 |
Similar Items
-
Myasthenia gravis
by: Massey Janice M, et al.
Published: (2007-11-01) -
Plasma asymmetric dimethylarginine in childhood asthma exacerbation
by: Adel S Bediwy, et al.
Published: (2018-01-01) -
Antagonism of the Neonatal Fc Receptor as an Emerging Treatment for Myasthenia Gravis
by: Karissa L. Gable, et al.
Published: (2020-01-01) -
Exacerbation of Pulmonary Fibrosis Following Single Lung Transplantation
by: Dawei Yang, et al.
Published: (2012-01-01) -
COPD exacerbations : aetiology, effects on the airways and plasma fibrinogen
by: Seemungal, Terence Anand Rao
Published: (2002)